KKR agrees to take Integer Holdings private for $5.7 billion
KKR agreed to buy medical device contract manufacturer Integer Holdings for about $5.7 billion in an all-cash take-private deal.
Global investment firm KKR said it has agreed to buy device manufacturer Integer Holdings for about $5.7 billion. An affiliate of funds managed by KKR will acquire all of Integer's outstanding shares in an all-cash transaction, with stockholders receiving about $127 per share.
The price is a more than 51% premium to Integer's closing price on April 29, before the company launched a strategic review in April. Integer's shares had risen nearly 20% on Friday after a Wall Street Journal report that the companies were nearing a deal.
The companies expect to close the transaction before the end of the year, subject to regulatory approvals and support from Integer shareholders. Integer reported second-quarter sales of $464 million, down 2.6%, and serves medtech firms including Abbott, Boston Scientific and Medtronic.
Deal facts
- Target
- Integer Holdings
- Business
- Medical device contract development and manufacturing organization making electrophysiology catheters, cardiac leads and batteries
- Buyer
- KKR
- Sponsor
- KKR
- Deal type
- Platform
- Value
- $5.7 billion
- Status
- Announced
- Announced
- Monday, August 3, 2026
Sources
- finance.yahoo.comAug 3, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.